Laurion Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,317
Closed -$340K 1109
2019
Q1
$340K Buy
10,317
+1,949
+23% +$60.7K ﹤0.01% 687
2018
Q4
$269K Sell
8,368
-1,205
-13% -$45.5K ﹤0.01% 885
2018
Q3
$411K Buy
+9,573
New +$452K ﹤0.01% 874
2018
Q2
Sell
-15,900
Closed -$631K 1518
2018
Q1
$631K Buy
+15,900
New +$589K 0.01% 959
2017
Q4
Sell
-9,464
Closed -$351K 1756
2017
Q3
$351K Sell
9,464
-2,159
-19% -$81.1K ﹤0.01% 1293
2017
Q2
$431K Buy
+11,623
New +$379K ﹤0.01% 1310
2014
Q3
Sell
-51,300
Closed -$1.13M 373
2014
Q2
$1.13M Buy
+51,300
New +$975K 0.02% 207

Other funds holding PAHC

Laurion Capital Management's PAHC Position: Q2 2019 in Review

Laurion Capital Management sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 10,317 shares — an estimated $340K sold.

Laurion Capital Management first reported a position in PAHC in Q2 2014 and held it in 7 quarters. The position peaked at $1.13M in Q2 2014. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Laurion Capital Management reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Laurion Capital Management sold 10,317 Phibro Animal Health shares in Q2 2019, an estimated $340K.
  • Laurion Capital Management first reported a position in Phibro Animal Health in Q2 2014 and held it in 7 quarters.
  • Laurion Capital Management's Phibro Animal Health position peaked at $1.13M in Q2 2014.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.